Lataa...
Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
Fluoroquinolones have been in clinical use for over 50 years with significant efficacy. However, increasing resistance and emergence of some marked adverse events have limited their usage. The most recently approved class member, delafloxacin, is the only available anionic (non-zwitterionic) fluoroq...
Tallennettuna:
| Julkaisussa: | Clin Infect Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452001/ https://ncbi.nlm.nih.gov/pubmed/30957164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy1079 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|